Posted in | News | Nanobusiness

MMFX Technologies Corporation Receives Financing from Institutional Investors

MMFX Technologies Corporation, an Irvine-based materials science company that, among other things, uses nanotechnology to manufacture high-strength, corrosion-resistant steel, has received a $55 million commitment in secured debt financing. Axiom Capital Management Inc. acted as the procuring agent for the transaction.

MMFX has received $27 million of the financing and will receive the remaining $28 million upon the startup of its Welland, Ontario, Canada steel mill facility. The steel mill’s state-of-the-art equipment is designed to manufacture both conventional and MMFX high-tech steel.

By using the higher yield strength of MMFX steel over conventional Grade 60 steel, construction projects can be completed with 20% to 50% less steel and up to 60% lower labor costs, changing the way buildings, highways, and bridges are designed and built.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    CMC. (2019, March 19). MMFX Technologies Corporation Receives Financing from Institutional Investors. AZoNano. Retrieved on December 03, 2024 from https://www.azonano.com/news.aspx?newsID=6594.

  • MLA

    CMC. "MMFX Technologies Corporation Receives Financing from Institutional Investors". AZoNano. 03 December 2024. <https://www.azonano.com/news.aspx?newsID=6594>.

  • Chicago

    CMC. "MMFX Technologies Corporation Receives Financing from Institutional Investors". AZoNano. https://www.azonano.com/news.aspx?newsID=6594. (accessed December 03, 2024).

  • Harvard

    CMC. 2019. MMFX Technologies Corporation Receives Financing from Institutional Investors. AZoNano, viewed 03 December 2024, https://www.azonano.com/news.aspx?newsID=6594.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.